BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2003
View Archived Issues
Sunesis and Biogen to discover therapeutics for inflammatory and autoimmune diseases
Read More
Type 2 diabetic patients complete first six-month treatment course with Metformin GR
Read More
EntreMed licenses thalidomide analogues to Celgene
Read More
NDA for Ganite reactivated
Read More
Triangle files MAA for emtricitabine
Read More
Allos Therapeutics further expands oncology development pipeline
Read More
Abbott claims P2X antagonists for pain and urinary incontinence
Read More
New inhibitors of IL-12 and/or IL-4 signaling identified at Cell Therapeutics
Read More
Merck Frosst develops novel PDE4 inhibitors
Read More
Aminoalcohol beta3-adrenoceptor agonists and their use claimed by Fujisawa
Read More
Altana researchers investigate novel anti-H. pylori agents
Read More
New TGF-beta antagonists for cancer and other uses covered by Lilly patent
Read More
Protein kinase inhibitors discovered by Schering scientists
Read More
Japanese approval sought for Kissei's mitiglinide
Read More
Peginterferon alfa-2a submitted for approval as hepatitis therapy in Japan
Read More
Phase II study of RTX in interstitial cystitis commences
Read More
Iressa review by the FDA will take more time than anticipated
Read More
Merck intends to obtain full ownership of Banyu
Read More
ZymoGenetics and Novo Nordisk join forces to develop IL-21
Read More
New-generation TTS product cleared for human testing
Read More
Promising effects of AEOL-10113 in hyperoxic preterm fetal baboons
Read More
Ariad files IND for AP-23573
Read More
Infliximab granted priority review by the FDA for fistulizing CD
Read More
Moli-1901 granted orphan drug status in Europe
Read More
Yamanouchi submits NDA for YM-905 to treat overactive bladder
Read More
Muscarinic receptor antagonist with better selectivity for bladder over salivation than tolterodine
Read More
Prasterone to be reviewed by EMEA
Read More
Advisory committee recommends FDA approval of telithromycin for RTI
Read More